Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions(DDI) Among Osteoarthritis Patients

CompletedOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
Osteoarthritis
Sponsors
All Listed Sponsors
lead

NEMA Research, Inc.

INDUSTRY

NCT01177267 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions(DDI) Among Osteoarthritis Patients | Biotech Hunter | Biotech Hunter